http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107119104-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29b632692b06d615bdc9b6031a350b3a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5513c48dbf1089c14ef55ca7e520a026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4992e5cc487baaa6aaf6906fdd4dfc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7791c5908848e6dfb4b8afac91a92451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89477858b16620b0ca01c5bc61c596b8
publicationDate 2017-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107119104-A
titleOfInvention One kind judges the drug-fast method of triple negative breast cancer
abstract The present invention provides one kind and judges the drug-fast method of triple negative breast cancer, it is characterised in that including step:One:By the Chek2 gene silencings or knockout of tumour cell, the first cell line is obtained;Two:First cell line is divided into two groups, Chek2 is transferred to respectively WT GFP and Chek2 Y390C GFP genes;Three:Sort the cell containing GFP;Four:Using the medicine to be measured of various concentrations to Chek2 WT GFP cell lines and Chek2 Y390C GFP cell lines are stimulated;Five:Post-stimulatory cell line is centrifuged and is resuspended, if the Chek2 of survival Y390C The cell concentration of GFP cell lines is more than Chek2 WT GFP cell concentration, then DeGrain of the medicine to triple negative breast cancer.The present invention can quickly judge whether certain medicine can tell on to triple negative breast cancer.
priorityDate 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1111
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID739836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9796068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID497672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479450
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID140583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114212
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID353120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID518897
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9696
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395401
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12189
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398191
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID336998
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID672
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID768913
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403064
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50883
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID393162
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID609767
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID486338
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID827854
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300711
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458733
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374260

Total number of triples: 52.